Company Edge Therapeutics Inc Nasdaq
Equities
US2798701098
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frank Bedu-Addo
FOU | Founder | 59 | 14/03/19 |
Director of Finance/CFO | 55 | 12-03 | |
David Schaaf
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/22 |
Spencer Brown
CMP | Compliance Officer | 54 | 31/05/22 |
Gregory Conn
CTO | Chief Tech/Sci/R&D Officer | 69 | 31/12/04 |
Joe J. Dervan
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Glover
CHM | Chairman | 60 | 01/04/19 |
Otis Brawley
BRD | Director/Board Member | 64 | 02/11/20 |
Richard Sykes
BRD | Director/Board Member | 79 | 28/02/19 |
Director/Board Member | 65 | 20/02/20 | |
Gregory Freitag
BRD | Director/Board Member | 62 | 28/02/19 |
Frank Bedu-Addo
FOU | Founder | 59 | 14/03/19 |
Ilian Iliev
BRD | Director/Board Member | 48 | 07/04/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,679,275 | 35,209,588 ( 95.99 %) | 0 | 95.99 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.55% | 21.25B | |
-5.71% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |